Kepler Capital Markets Analysts Give Sartorius (FRA:SRT3) a €78.00 Price Target
Sartorius (FRA:SRT3) received a €78.00 ($96.30) price target from Kepler Capital Markets in a research report issued to clients and investors on Thursday, January 4th. The firm currently has a “neutral” rating on the stock. Kepler Capital Markets’ price objective would indicate a potential downside of 13.19% from the stock’s current price.
Several other equities analysts have also weighed in on the company. Berenberg Bank set a €85.00 ($104.94) price target on Sartorius and gave the company a “buy” rating in a research note on Wednesday, December 6th. Deutsche Bank set a €80.00 ($98.77) price objective on Sartorius and gave the stock a “neutral” rating in a research note on Friday, December 1st. Hauck & Aufhaeuser set a €60.00 ($74.07) price objective on Sartorius and gave the stock a “sell” rating in a research note on Thursday, October 26th. set a €78.00 ($96.30) price objective on Sartorius and gave the stock a “neutral” rating in a research note on Thursday, October 26th. Finally, Nord/LB set a €70.00 ($86.42) price objective on Sartorius and gave the stock a “sell” rating in a research note on Wednesday, October 25th. Three analysts have rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of €78.40 ($96.79).
Sartorius (FRA SRT3) traded down €1.55 ($1.91) during midday trading on Thursday, hitting €89.85 ($110.93). The company’s stock had a trading volume of 43,367 shares. Sartorius has a twelve month low of €63.72 ($78.67) and a twelve month high of €94.00 ($116.05). The stock has a market cap of $6,580.00 and a price-to-earnings ratio of 73.05.
Sartorius Company Profile
Sartorius Aktiengesellschaft provides laboratory and process technologies and equipment worldwide. The company operates through two divisions, Bioprocess Solutions, and Lab Products & Services. The Bioprocess Solutions division offers products, technologies, and services ranging from fermentation, cell cultivation, filtration, and purification to media storage and transportation for the biopharmaceutical industry.
Receive News & Ratings for Sartorius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius and related companies with MarketBeat.com's FREE daily email newsletter.